1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner
(
- Contribution to journal › Article
-
Mark
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
(
- Contribution to journal › Scientific review
-
Mark
APOE in the bullseye of neurodegenerative diseases : impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
(
- Contribution to journal › Scientific review
- 2021
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The human bone marrow harbors a CD45− CD11B+ cell progenitor permitting rapid microglia-like cell derivative approaches
(
- Contribution to journal › Article
-
Mark
Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease
(
- Contribution to journal › Article
- 2020
-
Mark
Hyperinflammation and Fibrosis in Severe COVID-19 Patients : Galectin-3, a Target Molecule to Consider
(
- Contribution to journal › Article
-
Mark
Diagnosis and long-term outcome in dogs with acute onset intracranial signs
(
- Contribution to journal › Article
- 2019
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
(
- Contribution to journal › Article